ARCT stock

Arcturus Therapeutics Holdings Inc (ARCT) financials · rev $82.0M

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Arcturus Therapeutics Holdings Inc (ARCT) rev $82.0M.

Cached annual income statement
LineFY2025FY2024
Revenue$82.0M$152.3M
Operating Income-$76.3M-$95.7M
Net Income-$65.8M-$80.9M
EPS (Diluted)-$2.40N/A
Cached annual balance sheet
LineFY2025FY2024
Total Assets$271.1M$344.1M
Current Assets$241.4M$306.0M
Cash & Equivalents$230.9M$237.0M
PP&E$6.74M$9.53M
Total Liabilities$57.2M$103.1M
Current Liabilities$36.4M$65.5M
Shareholders' Equity$214.0M$241.0M
Retained Earnings-$514.6M-$448.8M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$74.3M-$59.7M
CapEx$230.0K$648.0K
Investing Cash Flow-$230.0K-$648.0K
Financing Cash Flow$13.4M$5.42M
Net Change in Cash-$61.1M-$55.0M
Free Cash Flow-$74.5M-$60.4M
These statements as JSON? API free 100/day

FAQ

What is ARCT P/E and revenue?

Arcturus Therapeutics Holdings Inc (ARCT) rev $82.0M.

What is ARCT revenue?

Arcturus Therapeutics Holdings Inc last cached revenue is $82.0M (FY2025).

Is ARCT profitable?

Arcturus Therapeutics Holdings Inc last cached net income is -$65.8M (FY2025).

What are ARCT total assets?

Arcturus Therapeutics Holdings Inc last cached total assets are $271.1M (FY2025).

What is ARCT free cash flow?

Arcturus Therapeutics Holdings Inc last cached free cash flow is -$74.5M (FY2025).

Not investment advice. Cached statements, not a live tape.